The immune protection of OMP16-specific IgM against Brucella infection.

Authors

Yunyi Zhai, Kaihui Sun, Ye Yuan, Gawa Wudong, Shuan Qu, Yaxin Li, Yuanhao Yang, XiaoFang Liu, Dong Zhou, Wei Liu, Yaping Jin, Aihua Wang

Published in

BMC biology. Jul 15, 2026. Epub Jul 15, 2026.

Abstract

Brucellosis, a severe zoonotic infectious disease, poses substantial economic and health threats globally. The intracellular survival strategy of Brucella complicates disease control, highlighting the need for novel immunotherapeutic strategies such as antibody-based therapies and multi-epitope vaccines.
This study generated two IgM monoclonal antibodies (D3 and F5) against the conserved outer membrane protein OMP16 of Brucella using hybridoma technology. Peptide scanning and Western blot identified their linear epitopes (D3: ⁷⁷TLSKQAQW⁸⁴; F5: ¹²⁰RDFLASRG¹²⁷), which are highly conserved among major Brucella species. Integrated approaches-including molecular docking, alanine-scanning mutagenesis, and dot-blot assays-revealed key residues at the epitope interface that form stable bonds with antibody complementarity-determining regions (CDRs). Functionally, both antibodies activated the complement system, with F5 exhibiting significant complement-dependent bacteriolytic activity in vitro. Furthermore, in the presence of complement, D3 and F5 enhanced macrophage-mediated opsonophagocytosis and intracellular killing of Brucella abortus A19. In a mouse infection model, passive immunization with either antibody significantly alleviated infection-induced weight loss and splenomegaly and reduced bacterial load in the spleen.
Our study underscores the role of IgM antibodies in combating Brucella infection, offers insights for antibody-based immunotherapy, and provides a theoretical foundation for developing multi-epitope vaccines based on the conserved epitopes and critical residues.

PMID:
42458412
Bibliographic data and abstract were imported from PubMed on 16 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.